mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
0.3 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.3 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.3 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.3 |